Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Genmab A/S Dkk (GNMSF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,846,735
  • Shares Outstanding, K 61,281
  • Annual Sales, $ 359,310 K
  • Annual Income, $ 167,630 K
  • 60-Month Beta 0.14
  • Price/Sales 30.82
  • Price/Cash Flow 64.22
  • Price/Book 9.87
  • Price/Earnings ttm 54.81
  • Earnings Per Share ttm 3.22
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/27/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.28
  • Number of Estimates 2
  • High Estimate 1.34
  • Low Estimate 1.22
  • Prior Year 2.00
  • Growth Rate Est. (year over year) -36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
159.9304 +10.67%
on 02/22/19
177.1400 -0.08%
on 03/04/19
+13.0824 (+7.98%)
since 02/21/19
3-Month
143.8000 +23.09%
on 02/08/19
177.1400 -0.08%
on 03/04/19
+15.3000 (+9.46%)
since 12/21/18
52-Week
119.1000 +48.61%
on 10/25/18
213.0000 -16.90%
on 04/17/18
-33.5100 (-15.92%)
since 03/16/18

Most Recent Stories

More News
MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / January 31, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced today that in its lawsuit against Janssen Biotech and Genmab...

MOR : 22.94 (-2.09%)
GNMSF : 177.0000 (+0.60%)
Vertex's Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids

Vertex (VRTX) gains an EU approval for Orkambi to treat 2-5-year-old children suffering cystic fibrosis (CF).

GNMSF : 177.0000 (+0.60%)
VRTX : 181.53 (-0.56%)
ACOR : 13.13 (-6.55%)
ADRO : 3.67 (-5.17%)
Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference

Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation

GNMSF : 177.0000 (+0.60%)
DB : 8.21 (-2.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade GNMSF with:

Key Turning Points

2nd Resistance Point 177.0000
1st Resistance Point 177.0000
Last Price 177.0000
1st Support Level 177.0000
2nd Support Level 177.0000

See More

52-Week High 213.0000
Fibonacci 61.8% 177.1302
Last Price 177.0000
Fibonacci 50% 166.0500
Fibonacci 38.2% 154.9698
52-Week Low 119.1000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar